Triazolopyridines

Details for Australian Patent Application No. 2010324155 (hide)

Owner Bayer Pharma Aktiengesellschaft

Inventors Schulze, Volker; Koppitz, Marcus; Kosemund, Dirk; Schirok, Hartmut; Bader, Benjamin; Lienau, Philip; Wengner, Antje Margret; Briem, Hans; Holton, Simon; Siemeister, Gerhard; Prechtl, Stefan; Bomer, Ulf

Agent Davies Collison Cave

Pub. Number AU-A-2010324155

PCT Pub. Number WO2011/063908

Priority 09075535.6 30.11.09 EP

Filing date 17 November 2010

Wipo publication date 3 June 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/063908 Priority application(s): WO2011/063908

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010324184-Process for the manufacture of propylene oxide

2010324153-Method for regulating the supply of substituate during extracorporeal blood treatment and extracorporeal blood treatment device comprising a unit for regulating the supply of substituate